Skip to content

Tilosa: what changed

BE 0753.952.294NACE 47.730, Retail sale of pharmaceutical productsOther company

Position among the sector peers

What moved between 2024 and 2025

Net result for the year
€19,184
2024 · €22,016-€2,832
Equity
€58,434
2024 · €100,473-€42,040
Cash
€30,171
2024 · €62,890-€32,720
Balance sheet total
€70,195
2024 · €112,606-€42,411

Largest movements

2024 to 2025
Assets
  • Cash -€32,720

    down €32,720 (-52.0%), from €62,890 to €30,171

    mainly Contributions, distributions and other (-€61,224) and Investment in fixed assets (net) (-€1,485)

  • Current investments -€9,736

    down €9,736 (-32.5%), from €30,000 to €20,264

Equity and liabilities
  • Reserves -€42,040

    down €42,040 (-44.0%), from €95,473 to €53,434

Income statement
  • Gross operating margin -€2,298

    down €2,298 (-7.5%), from €30,684 to €28,387

  • Other operating charges +€718

    up €718 (+52.8%), from €1,360 to €2,078

  • Taxes -€572

    down €572 (-7.8%), from €7,384 to €6,811

  • Depreciation +€558

    up €558 (+180%), from €310 to €868

Change in the result, 2024 to 2025

effect on the result

For each income-statement line you see the change as its effect on the result. Higher costs lower the result, higher income raises it.

Result 2024 €22,016
Gross operating margin -€2,298
Depreciation -€558
Other operating charges -€718
Financial income +€116
Financial charges +€53
Taxes +€572
Result 2025 €19,184
raises the resultlowers the result

Derived cash bridge

cash 2024 to 2025

The bridge is derived from the 2024 and 2025 balance sheets and the 2025 result. There is no filed cash-flow statement. You see where the money came from and where it went.

From operations +€20,253
Investment +€8,251
Financing -€61,224
Cash 2024 €62,890
Net result for the year +€19,184
Depreciation +€868
Receivables within one year +€387
Deferred charges and accrued income +€185
Trade debts -€594
Tax, wage and social debts -€209
Other debts +€478
Accrued charges and deferred income -€46
Investment in fixed assets (net) -€1,485
Current investments +€9,736
Contributions, distributions and other -€61,224
Cash 2025 €30,171
brings cash intakes cash out
Every line side by side 38 lines
Line Code 2024 2025 Change %
Total assets 20/58 €112,606 €70,195 -€42,411 -37.7%
Fixed assets 21/28 €1,840 €2,457 +€617 +33.6%
Tangible fixed assets 22/27 €1,840 €2,457 +€617 +33.6%
Furniture and vehicles 24 €1,840 €2,457 +€617 +33.6%
Current assets 29/58 €110,767 €67,738 -€43,028 -38.8%
Amounts receivable within one year 40/41 €16,434 €16,047 -€387 -2.4%
Trade receivables 40 €10,857 €10,382 -€475 -4.4%
Other amounts receivable 41 €5,578 €5,665 +€88 +1.6%
Current investments 50/53 €30,000 €20,264 -€9,736 -32.5%
Cash at bank and in hand 54/58 €62,890 €30,171 -€32,720 -52.0%
Deferred charges and accrued income 490/1 €1,442 €1,257 -€185 -12.9%
Total equity and liabilities 10/49 €112,606 €70,195 -€42,411 -37.7%
Equity 10/15 €100,473 €58,434 -€42,040 -41.8%
Contributions 10/11 €5,000 €5,000 = 0.0%
Reserves 13 €95,473 €53,434 -€42,040 -44.0%
Distributable reserves 133 €95,473 €53,434 -€42,040 -44.0%
Profit (loss) carried forward 14 €0 €0 =
Amounts payable 17/49 €12,133 €11,762 -€371 -3.1%
Amounts payable within one year 42/48 €12,087 €11,762 -€325 -2.7%
Trade debts 44 €1,945 €1,352 -€594 -30.5%
Suppliers 440/4 €1,945 €1,352 -€594 -30.5%
Taxes, remuneration and social security 45 €10,139 €9,930 -€209 -2.1%
Taxes 450/3 €10,139 €7,804 -€2,336 -23.0%
Remuneration and social security 454/9 - €2,126 +€2,126
Other amounts payable 47/48 €2 €480 +€478 +25,560%
Accrued charges and deferred income 492/3 €46 €0 -€46 -100%
Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets 630 €310 €868 +€558 +180%
Other operating charges 640/8 €1,360 €2,078 +€718 +52.8%
Gross operating margin 9900 €30,684 €28,387 -€2,298 -7.5%
Operating profit (loss) 9901 €29,014 €25,441 -€3,573 -12.3%
Financial income 75/76B €565 €681 +€116 +20.4%
Recurring financial income 75 €565 €681 +€116 +20.4%
Financial charges 65/66B €179 €126 -€53 -29.6%
Recurring financial charges 65 €179 €126 -€53 -29.6%
Profit (loss) for the period before taxes 9903 €29,400 €25,995 -€3,405 -11.6%
Income taxes 67/77 €7,384 €6,811 -€572 -7.8%
Profit (loss) for the period 9904 €22,016 €19,184 -€2,832 -12.9%
Profit (loss) for the period to be appropriated 9905 €22,016 €19,184 -€2,832 -12.9%

Value

latest balance sheet 31-12-2025 · indication, not a valuation or advice

Indicative value of the equity

Indication, not a valuation or advice
€105,152 to €135,527

Midpoint €117,808 · 50% capitalised earnings, 50% adjusted equity

Capitalisation rate 12% result over 3 years earnings weight 50%

Worked out with Checked's starting values, not your estimate and not market data. Change the assumptions: the value follows.

Adjusted equity €58,434
Capitalised earnings €151,871 to €212,620
Indication €105,152 to €135,527

Adjusted equity

balance sheet 31-12-2025
Equity (10/15)
€58,434
Revaluation of assets
€0
Deferred tax on the revaluation
€0
Other adjustment
€0
Adjusted equity
€58,434

Capitalised earnings

net result for the year (9904)
2025
€19,184
2024
€22,016
2023
€22,586
2022
€27,459
2021
€41,060
Average result
€21,262
Divided by the capitalisation rate
14% / 12% / 10%
Capitalised earnings
€151,871 / €177,183 / €212,620

Limits of the indication

  • Checked holds no market prices or comparable transactions.
  • Anything after the latest accounts and items off the balance sheet (guarantees, leases, disputes) are left out.
  • Checked does not know the real value of buildings, stock and receivables. Enter your own revaluation or adjustment for it.
  • The result is not corrected for the manager's pay. If the company pays less or more than a market salary, the capitalised earnings are too high or too low.
  • The owner's role in the business, synergies for a buyer and the tax consequences of a sale are left out.

For a valuation to base a decision on, go to a company auditor or a certified accountant.

Calculation and sources

Source: filed annual accounts (NBB) and main activity (KBO). The movements compare the financial years ended 31 December 2024 and 31 December 2025. Green is a favourable move for that line, red an unfavourable one. The value is an indication, not a valuation or advice. Prepared on 17 November 2026 via checked.be.